View More Recent Stories

Jul 26, 2022 07:30AM Palatin Announces Preliminary Fourth Quarter Vyleesi® Net Product Revenue Increased 225% Over Prior Quarter
May 17, 2022 07:30AM Palatin Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
May 11, 2022 09:02AM Palatin to Report Third Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on May 17, 2022
Feb 15, 2022 07:30AM Palatin Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
Feb 10, 2022 07:30AM Palatin to Report Second Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on February 15, 2022
Jan 21, 2022 07:30AM Palatin Announces Presentation at the 2022 Crohn's and Colitis Congress
Jan 7, 2022 10:59AM Palatin to Present at H.C. Wainwright BioConnect Conference
Dec 28, 2021 07:30AM Palatin Technologies (PTN) Initiates Pivotal Phase 3 PL9643 MELODY-1 Clinical Trial in Patients with Dry Eye Disease
Dec 28, 2021 07:30AM Palatin Announces Initiation of Pivotal Phase 3 PL9643 MELODY-1 Clinical Trial in Patients with Dry Eye Disease
View More Recent Stories